Synthesis Route Optimization and Quality Control Research of High-Activity Heterocyclic Intermediate 2-Chloro-5-iodopyrimidine

In modern medicinal chemistry, the pyrimidine ring, as a valuable bioisostere, is widely present in the molecular structures of various kinase inhibitors and antiviral drugs. Specifically, 2-Chloro-5-iodopyrimidine has become a critical “building block” for constructing complex pharmaceutical frameworks via Suzuki or Sonogashira coupling reactions, thanks to the distinct reactivity of its two halogen sites.
Traditional synthesis routes often face challenges such as harsh reaction conditions, poor regioselectivity, and low utilization of iodinating reagents. Our R&D team has successfully achieved site-specific iodination under mild temperature ranges by introducing an efficient electrophilic substitution system, reducing isomeric impurities to below 0.05%. Simultaneously, addressing the purification pain points in large-scale production, we developed a multi-stage crystallization coupling process, ensuring the final product’s purity remains stable above 99.5%. This dedication to synthetic process refinement not only significantly reduces impurity risks in downstream API (Active Pharmaceutical Ingredient) production but also provides a solid foundation for global pharmaceutical companies to shorten R&D cycles and reduce pre-clinical research costs.